PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12935919::ACT037553

Myoki

Evidence text

Paper-level observation

Table 2: 'Lean muscle mass (g) ... Treatment (N = 38) 930.8 ... Difference between placebo and treatment (95% CI) 705.8 (433.40 to 978.16) p<0.01'.
tableConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
other
Comparator
=
Raw observation
930.8 g
Normalized measurement
=930.8 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
EAEYEHL
Standardization
ready simple
Assay conditions
"original_unit=g"

Source publication

The therapeutic potential of Myoki, a novel peptide in muscle atrophy: mechanisms and applications.

Frontiers in Pharmacology · 2026

DOI 10.3389/fphar.2026.1663850 PMC12935919
Parent mention

Related peptide identities

PEPDIA-PLP-000522

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.